OPC Pharmaceutical JSC (HOSE:OPC)

Market Cap	1.43T -9.7%
Revenue (ttm)	1.12T +15.9%
Net Income	115.91B +8.3%
EPS	1,809.68 +27.4%
Shares Out	64.05M
PE Ratio	12.32
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	952
Average Volume	101,195
Open	22,300
Previous Close	22,300
Day's Range	22,300 - 22,300
52-Week Range	21,000 - 25,400
Beta	0.16
RSI	47.32
Earnings Date	Jan 23, 2026

About OPC Pharmaceutical JSC

OPC Pharmaceutical Joint Stock Company engages in the processing, manufacturing, trading, importing, and exporting of traditional, herbal, and nature-based medicine in Vietnam and internationally. The company offers cardiovascular, nerve, vitamins and minerals, respiratory system, urinary tract, musculoskeletal system, external use, digestion, pain relief-anti-inflammatory, endocrine, and other drugs. It also offers health gifts; and nutrition products for health care, supplementing nutrients, nourishing the body, and boosting immunity. In addi...

• Industry: Pharmaceutical Preparations
• Founded: 1977
• Employees: 866
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: OPC

Financial Performance

In 2025, OPC Pharmaceutical JSC's revenue was 1.12 trillion, an increase of 15.94% compared to the previous year's 968.58 billion. Earnings were 115.91 billion, an increase of 27.37%.